Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Genius Sports Limited (NYSE: GENI) closed at $10.22 in the last session, up 0.59% from day before closing price of $10.16. In other words, the price has increased by $0.59 from its previous closing price. On the day, 3.99 million shares were traded. GENI stock price reached its highest trading level at $10.32 during the session, while it also had its lowest trading level at $9.902.
Ratios:
We take a closer look at GENI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.46. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 18, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Stevens Eric bought 79,373 shares for $9.38 per share.
Davison Jack bought 100,388 shares of GENI for $876,939 on Jan 17 ’25. On Jan 10 ’25, another insider, Davison Jack, who serves as the Officer of the company, bought 8,202 shares for $8.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2378909440 and an Enterprise Value of 2040246400. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.17 while its Price-to-Book (P/B) ratio in mrq is 3.77. Its current Enterprise Value per Revenue stands at 3.993 whereas that against EBITDA is -79.638.
Stock Price History:
The Beta on a monthly basis for GENI is 1.95, which has changed by 1.0 over the last 52 weeks, in comparison to a change of 0.05279863 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $11.16, while it has fallen to a 52-week low of $4.91. The 50-Day Moving Average of the stock is 7.25%, while the 200-Day Moving Average is calculated to be 23.86%.
Shares Statistics:
According to the various share statistics, GENI traded on average about 3.29M shares per day over the past 3-months and 3519160 shares per day over the past 10 days. A total of 239.82M shares are outstanding, with a floating share count of 216.07M. Insiders hold about 9.90% of the company’s shares, while institutions hold 76.50% stake in the company. Shares short for GENI as of 1743379200 were 29830707 with a Short Ratio of 9.06, compared to 1740700800 on 30922498. Therefore, it implies a Short% of Shares Outstanding of 29830707 and a Short% of Float of 14.050001000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
